Literature DB >> 17150334

EEG wavelet analyses of the striatum-substantia nigra pars reticulata-superior colliculus circuitry: audiogenic seizures and anticonvulsant drug administration in Wistar audiogenic rats (War strain).

Franco Rossetti1, Marcelo Cairrão Araujo Rodrigues, José Antônio Cortes de Oliveira, Norberto Garcia-Cairasco.   

Abstract

The importance of the substantia nigra pars reticulata (SNPr), striatum (STR) and superior colicullus (SC) in the blockade of experimental seizures is well known. But, in audiogenic seizures (brainstem tonic-clonic seizures), the anticonvulsant activity of these nuclei is still controversial. In the present study we aimed to analyze the STR-SNPr-CS circuitry in the audiogenic seizures of Wistar audiogenic rat (WAR). Behavioral and electroencephalographic (EEG) data were collected from WARs under no treatment or injection with systemic (phenobarbital) or intracerebral (intranigral) drugs (muscimol and phenobarbital). The main EEG frequency oscillation of STR, SNPr and SC seen before, during and after audiogenic seizures or during seizure protection, was determinated with wavelet spectral analyses. This method allows the association between behavior and EEG (video-EEG). Audiogenic seizures last only for half a minute in average, suggesting that the interruptions of seizures are probably not due to exhaustion. Systemic phenobarbital caused an acute and dose-dependent behavioral and EEGraphic anticonvulsant effect both in WARs. The dose of phenobarbital 15mg/kg protected animals almost completely, without side effects such as ataxia and sedation. In our data, this endogenous "natural" seizure blockade (or termination) seems to be similar to the "forced" seizure abolition, like the one caused by a systemic non-ataxic phenobarbital dose, because in both cases an intense decrease in the EEG main frequency oscillation can be seen in SNPr and SC. Intranigral phenobarbital or muscimol did not protect animals, and actually induced an increase in the main EEG frequency oscillation in SC. The main finding of the present study is that, in contrast to what is well believed about the incapacity to control audiogenic seizures by the striato-nigro-tectal circuitry, we collected here evidences that these nuclei are involved in the ability to block these seizures. However, the striato-nigro-tectal circuitry in WARs, a genetically developed strain, seems to have different functional mechanisms when compared with normal rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17150334     DOI: 10.1016/j.eplepsyres.2006.08.001

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  10 in total

1.  Impaired central respiratory chemoreflex in an experimental genetic model of epilepsy.

Authors:  Leonardo T Totola; Ana C Takakura; José Antonio C Oliveira; Norberto Garcia-Cairasco; Thiago S Moreira
Journal:  J Physiol       Date:  2016-10-27       Impact factor: 5.182

2.  Descending projections from the substantia nigra pars reticulata differentially control seizures.

Authors:  Evan Wicker; Veronica C Beck; Colin Kulick-Soper; Catherine V Kulick-Soper; Safwan K Hyder; Carolina Campos-Rodriguez; Tahiyana Khan; Prosper N'Gouemo; Patrick A Forcelli
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

Review 3.  Nanotechnology for delivery of drugs to the brain for epilepsy.

Authors:  Margaret F Bennewitz; W Mark Saltzman
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

4.  Energy Metabolism and Redox State in Brains of Wistar Audiogenic Rats, a Genetic Model of Epilepsy.

Authors:  Carlos Roberto Porto Dechandt; Gustavo Duarte Ferrari; Jonathas Rodrigo Dos Santos; José Antonio Cortes de Oliveira; Rui Milton Patrício da Silva-Jr; Alexandra Olimpio Siqueira Cunha; Norberto Garcia-Cairasco; Luciane Carla Alberici
Journal:  Front Neurol       Date:  2019-10-01       Impact factor: 4.003

5.  Behavioral and Molecular Effects Induced by Cannabidiol and Valproate Administration in the GASH/Sal Model of Acute Audiogenic Seizures.

Authors:  Giselda Cabral-Pereira; David Sánchez-Benito; Sandra M Díaz-Rodríguez; Jaime Gonçalves; Consuelo Sancho; Orlando Castellano; Luis J Muñoz; Dolores E López; Ricardo Gómez-Nieto
Journal:  Front Behav Neurosci       Date:  2021-01-22       Impact factor: 3.558

Review 6.  Cannabinoids in Audiogenic Seizures: From Neuronal Networks to Future Perspectives for Epilepsy Treatment.

Authors:  Willian Lazarini-Lopes; Raquel A Do Val-da Silva; Rui M P da Silva-Júnior; Alexandra O S Cunha; Norberto Garcia-Cairasco
Journal:  Front Behav Neurosci       Date:  2021-02-11       Impact factor: 3.558

7.  Increased TRPV1 Channels and FosB Protein Expression Are Associated with Chronic Epileptic Seizures and Anxiogenic-like Behaviors in a Preclinical Model of Temporal Lobe Epilepsy.

Authors:  Willian Lazarini-Lopes; Gleice Kelli Silva-Cardoso; Christie Ramos Andrade Leite-Panissi; Norberto Garcia-Cairasco
Journal:  Biomedicines       Date:  2022-02-10

8.  Putative Causal Variant on Vlgr1 for the Epileptic Phenotype in the Model Wistar Audiogenic Rat.

Authors:  Samara Damasceno; Pablo Augusto de Souza Fonseca; Izinara Cruz Rosse; Márcio Flávio Dutra Moraes; José Antônio Cortes de Oliveira; Norberto Garcia-Cairasco; Ana Lúcia Brunialti Godard
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

9.  Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures.

Authors:  Ryan T Cleary; Hongyu Sun; Thanhthao Huynh; Simon M Manning; Yijun Li; Alexander Rotenberg; Delia M Talos; Kristopher T Kahle; Michele Jackson; Sanjay N Rakhade; Gerard T Berry; Gerard Berry; Frances E Jensen
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

10.  Electroencephalography Based Fusion Two-Dimensional (2D)-Convolution Neural Networks (CNN) Model for Emotion Recognition System.

Authors:  Yea-Hoon Kwon; Sae-Byuk Shin; Shin-Dug Kim
Journal:  Sensors (Basel)       Date:  2018-04-30       Impact factor: 3.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.